Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
Add more filters

Publication year range
1.
Crit Rev Food Sci Nutr ; 63(22): 5488-5505, 2023.
Article in English | MEDLINE | ID: mdl-34978223

ABSTRACT

Although conventional drugs are widely used in the prevention and treatment of cardiovascular disease (CVD), they are being used less frequently due to concerns about possible side effects over the long term. There has been a renewed research interest in medicinal plant products, and their role in protecting the cardiovascular system and treating CVD, which are now being considered as potential alternatives to modern drugs. The most important mechanism causing damage to the myocardium after heart attack and reperfusion, is increased levels of free radicals and oxidative stress. Therefore, treatment approaches often focus on reducing free radicals or enhancing antioxidant defense mechanism. It has been previously reported that bioactive natural products can protect the heart muscle in myocardial infarction (MI). Since these compounds are readily available in fruits and vegetables, they could prevent the risk of MI if they are consumed daily. Although the benefits of a healthy diet are well known, many scientific studies have focused on whether pure natural compounds can prevent and treat MI. In this review we summarize the effects of curcumin, resveratrol, quercitin, berberine, and tanshinone on MI and CVD, and focus on their proposed molecular mechanisms of action.


Subject(s)
Biological Products , Myocardial Infarction , Humans , Biological Products/pharmacology , Biological Products/therapeutic use , Myocardial Infarction/drug therapy , Antioxidants/pharmacology , Antioxidants/therapeutic use , Resveratrol/pharmacology , Resveratrol/therapeutic use , Free Radicals/therapeutic use
2.
Oncology ; 100(10): 555-568, 2022.
Article in English | MEDLINE | ID: mdl-35850102

ABSTRACT

BACKGROUND: Altered glucose metabolism is associated with chemoresistance in colorectal cancer (CRC). This study aimed to illustrate the molecular mechanisms of glucose-mediated chemoresistance against irinotecan, a topoisomerase I inhibitor, focusing on the distinct roles of metabolites such as pyruvate and ATP in modulating cell death and proliferation. METHODS: Four human CRC cell lines, tumorspheres, and mouse xenograft models were treated with various doses of irinotecan in the presence of various concentrations of glucose, pyruvate, or ATP-encapsulated liposomes. RESULTS: In this study, human CRC cell lines treated with irinotecan in high glucose displayed increased cell viability and larger xenograft tumor sizes in mouse models compared to those treated in normal glucose concentrations. Irinotecan induced apoptosis and necroptosis, both mitigated by high glucose. Liposomal ATP prevented irinotecan-induced apoptosis, while it did not affect necroptosis. In contrast, pyruvate attenuated the receptor-interacting protein kinase 1/3-dependent necroptosis via free radical scavenging without modulating apoptotic levels. Regarding the cell cycle, liposomal ATP aggravated the irinotecan-induced G0/G1 shift, whereas pyruvate diminished the G0/G1 shift, showing opposite effects on proliferation. Last, tumorsphere structural damage, an index of solid tumor responsiveness to chemotherapy, was determined. Liposomal ATP increased tumorsphere size while pyruvate prevented the deformation of spheroid mass. CONCLUSIONS: Glucose metabolites confer tumor chemoresistance via multiple modes of action. Glycolytic pyruvate attenuated irinotecan-induced necroptosis and potentiated drug insensitivity by shifting cells from a proliferative to a quiescent state. On the other hand, ATP decreased irinotecan-induced apoptosis and promoted active cell proliferation, contributing to tumor recurrence. Our findings challenged the traditional view of ATP as the main factor for irinotecan chemoresistance and provided novel insights of pyruvate acting as an antioxidant responsible for drug insensitivity, which may shed light on the development of new therapies against recalcitrant cancers.


Subject(s)
Colorectal Neoplasms , Glucose , Adenosine Triphosphate/pharmacology , Adenosine Triphosphate/therapeutic use , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Apoptosis , Cell Line, Tumor , Cell Proliferation , Colorectal Neoplasms/pathology , Drug Resistance, Neoplasm , Free Radicals/pharmacology , Free Radicals/therapeutic use , Glucose/metabolism , Glucose/pharmacology , Glucose/therapeutic use , Humans , Irinotecan/pharmacology , Liposomes/pharmacology , Liposomes/therapeutic use , Mice , Neoplasm Recurrence, Local/drug therapy , Protein Kinases/pharmacology , Protein Kinases/therapeutic use , Pyruvic Acid/pharmacology , Pyruvic Acid/therapeutic use , Topoisomerase I Inhibitors/pharmacology , Topoisomerase I Inhibitors/therapeutic use
3.
Nanomedicine ; 45: 102586, 2022 09.
Article in English | MEDLINE | ID: mdl-35868519

ABSTRACT

No medication has been approved for secondary injuries after traumatic brain injury (TBI). While free radicals are considered a major mediator of secondary injury, conventional antioxidants only have modest clinical efficacy. Here, we synthesized CX201 consisting of core cerium oxide nanoparticles coated with 6-aminocaproic acid and polyvinylpyrrolidone in aqueous phase. CX201 with 3.49 ± 1.11 nm of core and 6.49 ± 0.56 nm of hydrodynamic diameter showed multi-enzymatic antioxidant function. Owing to its excellent physiological stability and cell viability, CX201 had a neuroprotective effect in vitro. In a TBI animal model, an investigator-blinded randomized experiment showed a single intravenously injected CX201 significantly improved functional recovery compared to the control. CX201 reduced lipid peroxidation and inflammatory cell recruitment at the damaged brain. These suggest ultrasmall CX201 can efficiently reduce secondary brain injuries after TBI. Given the absence of current therapies, CX201 may be proposed as a novel therapeutic strategy for TBI.


Subject(s)
Brain Injuries, Traumatic , Brain Injuries , Cerium , Nanoparticles , Neuroprotective Agents , Aminocaproic Acid/therapeutic use , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Brain Injuries, Traumatic/drug therapy , Cerium/therapeutic use , Free Radicals/therapeutic use , Neuroprotective Agents/therapeutic use , Polymers/therapeutic use , Povidone
4.
Drug Chem Toxicol ; 45(5): 2014-2023, 2022 Sep.
Article in English | MEDLINE | ID: mdl-33682557

ABSTRACT

Morel mushrooms, Morchella species are highly nutritious and excellently edible wild mushrooms abundantly growing in Kashmir Himalayas. The free radical scavenging, anti-inflammatory, and arthritis edema-inhibiting properties of bioactive extract of Morchella elata (EAE) were evaluated. EAE inhibited 53.2% formalin-induced paw edema at a dose of 500 mg/kg b.wt and 75.0% croton oil-induced skin inflammation at a dose of 50 mg topical application. EAE exhibited 51.8% COX inhibiting activity at a concentration of 100 µg/ml when assayed using LPS-stimulated RAW 264.7 cells exposed to the extract. NF-kB inhibiting activity of EAE was assayed using Lentix-293T P65 Ds Red stable cell line. High-throughput fluorescent imaging and flow cytometry showed profound ability of EAE to inhibit NF-kB activity. HPTLC analysis revealed that EAE is composed of several chemical components. The mushroom is a source of therapeutically useful functional food that can provide relief in arthritis.


Subject(s)
Agaricales , Arthritis , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Arthritis/chemically induced , Arthritis/drug therapy , Edema/chemically induced , Edema/drug therapy , Free Radicals/therapeutic use , NF-kappa B , Plant Extracts/chemistry
5.
Acta Clin Croat ; 58(4): 726-736, 2019 Dec.
Article in English | MEDLINE | ID: mdl-32595258

ABSTRACT

This review article is focused on the impact of antioxidants and prooxidants on health with emphasis on the type of antioxidants that should be taken. Medical researchers suggest that diet may be the solution for the control of chronic diseases such as cardiovascular complications, hypertension, diabetes mellitus, and different cancers. In this survey, we found scientific evidence that the use of antioxidants should be limited only to the cases where oxidative stress has been identified. This is often the case of specific population groups such as postmenopausal women, the elderly, infants, workers exposed to environmental pollutants, and the obese. Before starting any supplementation, it is necessary to measure oxidative stress and to identify and eliminate the possible sources of free radicals and thus increased oxidative stress.


Subject(s)
Antioxidants/pharmacology , Antioxidants/therapeutic use , Diabetes Mellitus/drug therapy , Diabetes Mellitus/physiopathology , Free Radicals/pharmacology , Free Radicals/therapeutic use , Oxidative Stress/drug effects , Adult , Aged , Aged, 80 and over , Chronic Disease/therapy , Female , Humans , Male , Middle Aged
6.
Cancer Prev Res (Phila) ; 17(4): 157-167, 2024 Apr 02.
Article in English | MEDLINE | ID: mdl-38286439

ABSTRACT

Cigarette smoke is a rich source of free radicals that can promote oxidative stress and carcinogenesis, including head and neck squamous cell carcinoma (HNSCC) development; importantly, 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) and 8-iso-prostaglandin F2α (8-isoprostane) are biomarkers of oxidative stress. Several mechanisms, including the antioxidant properties of black raspberry (BRB), account for their chemopreventive effects. In the present clinical trial, we tested the hypothesis that BRB administration reduces biomarkers levels of oxidative stress in buccal cells and urine of smokers. One week after enrolling 21 smokers, baseline buccal cells and urine samples were collected before the administration of BRB lozenges for 8 weeks (5/day, 1 gm BRB/lozenge). Buccal cells and urine samples were collected at the middle and the end of BRB administration. The last samples were collected after the BRB cessation (washout period). We analyzed levels of 8-oxodG and 8-isoprostane (LC/MS-MS), urinary cotinine (ELISA), and creatinine (spectrophotometry). BRB significantly reduced the levels of 8-oxodG by 17.08% (P = 0.00079) in buccal cells and 12.44% (P = 0.034) in urine at the middle of BRB administration as compared with baseline; the corresponding values at the end of BRB administration were 16.46% (P = 0.026) in buccal cells and 25.72% (P = 0.202) in urine. BRB had no significant effect on the levels of urinary 8-isoprostane. BRB's capacity to inhibit 8-oxodG formation of smokers' buccal cells and urine is clearly evident and the reduction in 8-oxodG suggests that antioxidant abilities are central to BRB's HNSCC chemopreventive properties. PREVENTION RELEVANCE: Cigarette smoke contains highly active components namely free radicals that can promote oxidative stress and oral cancer. We found that black raspberry (BRB) inhibited the formation of oxidative stress markers in the oral cavity and urine of smokers suggesting the antioxidant abilities of BRB in preventing oral cancer.


Subject(s)
Head and Neck Neoplasms , Mouth Neoplasms , Rubus , Humans , 8-Hydroxy-2'-Deoxyguanosine/pharmacology , 8-Hydroxy-2'-Deoxyguanosine/therapeutic use , Antioxidants/pharmacology , Biomarkers/urine , Deoxyguanosine/pharmacology , Deoxyguanosine/therapeutic use , Deoxyguanosine/urine , Free Radicals/pharmacology , Free Radicals/therapeutic use , Mouth Mucosa/pathology , Mouth Neoplasms/etiology , Mouth Neoplasms/prevention & control , Mouth Neoplasms/drug therapy , Oxidative Stress , Smokers , Squamous Cell Carcinoma of Head and Neck
7.
ACS Appl Mater Interfaces ; 15(29): 34436-34450, 2023 Jul 26.
Article in English | MEDLINE | ID: mdl-37415554

ABSTRACT

Tumors have become the biggest obstacle to human health, and there are various treatment methods at present. Photothermal therapy (PTT) is usually ineffective and does not inhibit tumor progression due to the inability of the lasers to penetrate deeply. Therefore, most existing studies chose a 1064 nm laser with stronger penetrating power; meanwhile, studies have shown that the inclusion of harmful free radicals can significantly improve the antitumor efficacy. Herein, TiO nanosheets (NSs) were creatively prepared and encapsulated with an alkyl radical generator {2,2'-azobis[2-(2-imidazoline-2-yl)propane] dihydrochloride, [AIPH]} in sodium alginate (ALG) hydrogel for effective tumor killing by PTT and pairing with dangerous free radicals. TiO NSs were obtained by the liquid-phase exfoliation method, together with AIPH, which were in situ coencapsulated multifunctional hydrogels formed by the combination of Ca2+ and ALG. This ALG hydrogel could enrich TiO NSs and AIPH at the tumor site for a long time, and through the excellent photothermal properties of TiO NSs, AIPH could slowly and effectively generate alkyl radicals at the tumor site, which, in turn, gave it a better antitumor effect compared with that of TiO NSs in the deep hypoxic environment of the tumor. The AIPH + TiO + ALG hydrogel has distinctive anticancer capabilities based on the results of both in vivo and in vitro experiments. This material also has good biosafety. By combining PTT and free radical treatment, this work provides a novel therapeutic method to achieve oxygen-independent free radical production and enhance therapeutic efficacy.


Subject(s)
Hydrogels , Neoplasms , Humans , Hydrogels/chemistry , Photothermal Therapy , Phototherapy , Neoplasms/drug therapy , Thermodynamics , Free Radicals/therapeutic use , Cell Line, Tumor
8.
Curr Hypertens Rev ; 19(1): 7-18, 2023.
Article in English | MEDLINE | ID: mdl-37183397

ABSTRACT

Oxidative stress is one of the main mechanisms involved in the pathophysiology of arterial hypertension, inducing direct effects on the vasculature, and contributing to endothelial dysfunction and consequent impairment of vascular relaxation. Despite a large number of pharmacological treatments available, intolerable side effects are reported, which makes the use of natural antioxidants a promising and complementary alternative for the prevention and treatment of hypertension. From this perspective, the current review aims to investigate and characterize the main antioxidants of natural origin for the treatment of hypertension. Antioxidants act in the inhibition or extinction of chemical reactions involving free radicals and consequently reduce the occurrence of damage caused by these cellular components. The main natural antioxidants for treating hypertension include caffeic acid, ferulic acid, curcumin, apocynin, quercetin, lipoic acid, and lycopene. The effects associated with these antioxidants, which make them therapeutic targets for decreasing high blood pressure, include increased activation of antioxidant enzymes, stimulation of nitric oxide bioavailability, and reduction in angiotensin-converting enzyme activity, arginase, and NADPH oxidase, whose effects contribute to reducing oxidative stress, improving endothelial function, and preventing cardiovascular dysfunctions. Thus, several products with antioxidant properties that are available in nature and their application in the treatment of hypertension are described in the literature. The therapeutic effects of these products seem to regulate several parameters related to arterial hypertension, in addition to combating and preventing the deleterious effects related to the disease.


Subject(s)
Antioxidants , Hypertension , Humans , Antioxidants/adverse effects , Antihypertensive Agents/adverse effects , Hypertension/diagnosis , Hypertension/drug therapy , Oxidative Stress/physiology , Free Radicals/pharmacology , Free Radicals/therapeutic use
9.
Curr Neuropharmacol ; 20(6): 1046-1072, 2022.
Article in English | MEDLINE | ID: mdl-34781871

ABSTRACT

BACKGORUND: Oxidative stress is one of the main contributing factors involved in cerebral biochemical impairment. The higher susceptibility of the central nervous system to reactive oxygen species mediated damage could be attributed to several factors. For example, neurons use a greater quantity of oxygen, many parts of the brain have higher concentraton of iron, and neuronal mitochondria produce huge content of hydrogen peroxide. In addition, neuronal membranes have polyunsaturated fatty acids, which are predominantly vulnerable to oxidative stress (OS). OS is the imbalance between reactive oxygen species generation and cellular antioxidant potential. This may lead to various pathological conditions and diseases, especially neurodegenerative diseases such as, Parkinson's, Alzheimer's, and Huntington's diseases. OBJECTIVES: In this study, we explored the involvement of OS in neurodegenerative diseases. METHODS: We used different search terms like "oxidative stress and neurological disorders" "free radicals and neurodegenerative disorders" "oxidative stress, free radicals, and neurological disorders" and "association of oxidative stress with the name of disorders taken from the list of neurological disorders. We tried to summarize the source, biological effects, and physiologic functions of ROS. RESULTS: Finally, it was noted that more than 190 neurological disorders are associated with oxidative stress. CONCLUSION: More elaborated studies in the future will certainly help in understanding the exact mechanism involved in neurological diseases and provide insight into revelation of therapeutic targets.


Subject(s)
Neurodegenerative Diseases , Oxidative Stress , Antioxidants/pharmacology , Free Radicals/pharmacology , Free Radicals/therapeutic use , Humans , Neurodegenerative Diseases/drug therapy , Reactive Oxygen Species
10.
Acta Biomater ; 141: 140-150, 2022 03 15.
Article in English | MEDLINE | ID: mdl-35081433

ABSTRACT

Most dry eye syndromes (DES) are caused by oxidative stress and an overactive inflammatory response, leading to tear deficiency and excessive tear evaporation. Conventional eye drops for DES treatment require high doses and frequent administration due to their insufficient precorneal residence time. To overcome these problems, in this study, we have developed carbonized nanogels (CNGs) via the straightforward pyrolysis of lysine hydrochloride (Lys) to provide a long-lasting eye drop formulation for topical DES therapy. This methodology thermally converts Lys-into nitrogen-doped crosslinked polymers with embedded nanographitic structures, which enable efficient free radical scavenging. The cationic and crosslinked polymeric features of the Lys-CNGs also prolong the precorneal retention time and improve ocular bioavailability. These Lys-CNGs exhibit high biocompatibility with corneal epithelial cells both in vitro and in vivo, indicating their safety as eye drops. In a DES rabbit model, a single dose of Lys-CNGs (50 µg mL-1) can effectively alleviate the signs of DES within 4 days, whereas multiple treatments of 10-fold higher concentration of cyclosporine A are needed to achieve similar therapeutic effects (one dose every 12 h; 500 µg mL-1). The topical administration of Lys-CNGs enable a reduced therapeutic dose and extended dosing interval, thereby demonstrating a superior therapeutic efficacy compared to the commercial cyclosporine A eye drops. These Lys-CNGs, which exhibit significant free radical scavenging, anti-inflammatory activity, high biocompatibility, and a remarkable ocular bioadhesive property, hold great potential as a long-lasting eye drop formulation for the treatment of dry eye disease. STATEMENT OF SIGNIFICANCE: Multifunctional nanobiomaterial-based eye drops can render an ideal pharmaceutical formulation for the treatment of a variety of ocular surface diseases. To our knowledge, this is the first report describing the development of carbonized nanogels as topically administered therapeutics for alleviating dry eye syndrome (DES). We present evidence that the thermal transformation of lysine hydrochloride into carbonized nanogels (Lys-CNGs) endows superior antioxidant, anti-inflammatory, and bioadhesive properties. While a single dose of Lys-CNGs (50 µg mL-1) is sufficient to relieve the symptoms of DES for 4 days, multiple treatments of 10-fold higher concentration of commercially available cyclosporine eye drops are needed to achieve similar therapeutic outcomes (one dose every 12 h; 500 µg mL-1), suggesting an effective and long-lasting ocular carbonized nanomedicine.


Subject(s)
Dry Eye Syndromes , Lysine , Animals , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Antioxidants/pharmacology , Cyclosporine , Dry Eye Syndromes/drug therapy , Free Radicals/therapeutic use , Lysine/pharmacology , Nanogels , Ophthalmic Solutions/pharmacology , Ophthalmic Solutions/therapeutic use , Rabbits
11.
J Food Biochem ; 46(10): e14265, 2022 10.
Article in English | MEDLINE | ID: mdl-35661366

ABSTRACT

There are no medical drugs that provide an acceptable weight loss with minimal adverse effects. This study evaluated the Moringa peregrina (MP) seed extract's anti-obesity effect. Twenty-four (6/each group) male Sprague Dawley rats were divided into group Ι (control), group ΙΙ (high-fat diet [HFD]), group ΙΙΙ (HFD+ MP [250 mg/kg b.wt]), and group ΙV (HFD+ MP [500 mg/kg b.wt]). MP administration significantly ameliorated body weight gains and HFD induced elevation in cholesterol, triglycerides, LDL, and reduced HDL. Moreover, MP seed oil showed high free radical-scavenging activity, delayed ß-carotene bleaching and inhibited lipoprotein and pancreatic lipase enzymes. High-performance liquid chromatography (HPLC) revealed three major active components: crypto-chlorogenic acid, isoquercetin, and astragalin. Both quantitative Real-time PCR (RT-PCR) and western blotting revealed that MP seeds oil significantly decreased the expression of lipogenesis-associated genes such as peroxisome proliferator-activated receptors gamma (PPARγ) and fatty acid synthase (FAS) and significantly elevated the expression of lipolysis-associated genes (acetyl-CoA carboxylase1, ACCl). The oil also enhanced phosphorylation of AMP-activated protein kinase alpha (AMPK-α) and suppressed CCAAT/enhancer-binding protein ß (C/EBPß). In conclusion, administration of M. peregrina seeds oil has anti-obesity potential in HFD-induced obesity in rats. PRACTICAL APPLICATIONS: M. peregrina seeds oil had a potential anti-obesity activity that may be attributed to different mechanisms. These included decreasing body weight, and body mass index and improving lipid levels by decreasing total cholesterol, triglycerides and LDL-C, and increasing HDL-C. Also, M. peregrina seeds oil regulated adipogenesis-associated genes, such as downregulating the expression of (PPARγ, C/EBPα, and FAS) and improving and upregulating the expression and phosphorylation of AMPKα and ACCl. Despite that M. peregrina extract has reported clear anti-obesity potential through animal and laboratory studies, the available evidence-based on human clinical trials are very limited. Therefore, further studies are needed that could focus on clinical trials investigating anti-obesity potential different mechanisms of M. peregrina extract in humans.


Subject(s)
Diet, High-Fat , Moringa , AMP-Activated Protein Kinases/genetics , AMP-Activated Protein Kinases/pharmacology , Acetyl Coenzyme A/metabolism , Acetyl Coenzyme A/pharmacology , Acetyl Coenzyme A/therapeutic use , Adipocytes , Animals , Antioxidants/metabolism , Body Weight , Chlorogenic Acid/metabolism , Cholesterol/metabolism , Cholesterol, LDL/metabolism , Diet, High-Fat/adverse effects , Fatty Acid Synthases/metabolism , Fatty Acid Synthases/pharmacology , Fatty Acid Synthases/therapeutic use , Free Radicals/metabolism , Free Radicals/pharmacology , Free Radicals/therapeutic use , Humans , Lipase/metabolism , Male , Moringa/metabolism , Obesity/drug therapy , Obesity/etiology , PPAR gamma/genetics , PPAR gamma/metabolism , Plant Extracts/metabolism , Plant Extracts/pharmacology , Plant Oils/metabolism , Rats , Rats, Sprague-Dawley , Seeds/metabolism , Triglycerides/metabolism , beta Carotene
12.
ACS Appl Mater Interfaces ; 13(32): 38114-38126, 2021 Aug 18.
Article in English | MEDLINE | ID: mdl-34357760

ABSTRACT

The efficacy of sonodynamic therapy (SDT) is largely dependent upon oxygen availability to generate deleterious reactive oxygen species, and as such, hypoxic microenvironments greatly constrain the efficacy of SDT. Development of free radical generators that are not dependent on oxygen and related combination treatment strategies thus have the potential to enhance the antitumor potential of SDT. Combined treatment strategies are expected to improve the efficacy of sonodynamic antitumor therapy. As metal-organic framework (MOF) platforms are highly amenable to integration with other therapeutic approaches, we herein report the development of tumor microenvironment (TME)-responsive nanoparticles constructed by embedding the azo initiator 2,2'-azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride (AIPH) into hypoxia-triggered copper metal-organic framework (Cu-MOF) nanovectors to achieve synergistic sono-chemodynamic therapy in an orthotopic murine pancreatic carcinoma model system. When exposed to hypoxic conditions within the TME, this Cu-MOF structure underwent degradation, leading to the release of Cu2+ and AIPH. Cu2+ was then able to deplete local glutathione stores, resulting in the reduction of Cu2+ to Cu+, which then reacts with endogenous H2O2 in a Fenton-like reaction to yield cytotoxic hydroxyl radicals (•OH) for chemodynamic therapy. When exposed to ultrasound irradiation, AIPH further degraded in an oxygen-independent manner to yield nitrogen bubbles and alkyl radicals, the former of which enhanced the ability of these nanoparticles to penetrate deeply into the tumor. The resultant radicals induced substantial DNA damage and apoptotic cell death within target tumors under different levels of oxygen availability. As such, this hypoxic TME-responsive synergistic sono-chemodynamic approach offers an ideal means of achieving oxygen-independent free radical generation and enhanced treatment efficacy.


Subject(s)
Free Radicals/therapeutic use , Metal-Organic Frameworks/pharmacology , Pancreatic Neoplasms/therapy , Photochemotherapy/methods , Ultrasonic Therapy/methods , Animals , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Human Umbilical Vein Endothelial Cells , Humans , Mice , Tumor Hypoxia , Pancreatic Neoplasms
13.
Free Radic Res ; 54(8-9): 687-693, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32972269

ABSTRACT

Found in various natural food products, many in vitro evidence indicated that resveratrol (RES) has been linked to neuroprotective and cardioprotective effects and prevent cancer development. However, human clinical trials have been conducted with varying results, making the usage of RES controversial. In this paper, we demonstrated that the drug RES could be conjugated with the high levels of endogenous GS• in cancer cells. 5,5-Dimethyl-1-Pyrroline-N-Oxide (DMPO) was employed to capture the GS•. The molecular mechanism of the reaction between RES and GS• was further studied by UV-Vis spectrometry, mass spectrometry and Density Functional Theory (DFT) calculations. Besides, the formation of the adduct GS-RES in cancer cell was obtained when RES was added during incubation. Further study indicated that over 77.6% of the RES was consumed in cancer cells. This study suggested that endogenous GS• may be one of the important factors to cause the depletion of anti-tumour drugs during chemotherapy, which should be paid special attention in clinical therapeutics and drug development.


Subject(s)
Free Radicals/therapeutic use , Glutathione/metabolism , Neoplasms/genetics , Neoplasms/metabolism , Resveratrol/therapeutic use , Free Radicals/pharmacology , Humans , Resveratrol/pharmacology
14.
In Vivo ; 23(4): 599-611, 2009.
Article in English | MEDLINE | ID: mdl-19567396

ABSTRACT

The antimumor effect of antioxidant vitamins (C, E and beta-carotene) as well as of the vitamins B1 up to B6 and B11 under the action of oxidizing (OH, O(2)(*-)) and reducing free radicals (e(aq)(-), H) is discussed. In addition, the synergistic action of vitamins on cytostatic agents under the influence of free radicals and the involved reaction mechanisms are briefly discussed. The very fast kinetics of electron transfer taking place within a biological molecule (vitamin B11) is shown for demonstration of the complicated free radical processes in the organism.


Subject(s)
Antioxidants/chemistry , Antioxidants/therapeutic use , Neoplasms/drug therapy , Vitamins/chemistry , Vitamins/therapeutic use , Electrons , Free Radicals/chemistry , Free Radicals/therapeutic use , Humans , Oxidation-Reduction
15.
Methods Mol Biol ; 1866: 199-210, 2019.
Article in English | MEDLINE | ID: mdl-30725417

ABSTRACT

Colloidal selenium, was first used to treat cancer as early as 1911 in both humans and mice. Selenium was identified as the toxic component in forage plants of sheep, cattle, and horses in the 1930s. The animal toxicity of selenium compounds was determined to be from the metabolism by animals of the elevated concentrations of Se-methylselenocysteine and selenomethionine in plants. The metabolism of both Se-methylselenocysteine and selenomethionine by animals gives rise to the metabolite, methylselenide (CH3Se-), which if in sufficient concentration oxidizes thiols and generates superoxide and other reactive oxygen species. Cancer cells that may overly express methionine gamma-lyase, or beta-lyase (methioninase), by induced viral genomic expression, are susceptible to free radical-induced apoptosis from selenomethionine or Se-methylselenocysteine supplementation.


Subject(s)
Carbon-Sulfur Lyases/therapeutic use , Free Radicals/therapeutic use , Selenium/therapeutic use , Selenomethionine/therapeutic use , Animals , Antineoplastic Agents , Humans , Neoplasms/pathology , Neoplasms/prevention & control , Selenomethionine/chemistry
16.
Phytomedicine ; 55: 200-213, 2019 Mar 01.
Article in English | MEDLINE | ID: mdl-30668430

ABSTRACT

BACKGROUND: Hypertension is a major public health problem worldwide. It is an important risk factor for other cardiovascular diseases such as coronary artery disease, stroke, heart failure, atrial fibrillation, peripheral vascular disease, chronic kidney disease, and atherosclerosis. PURPOSE: There is strong evidence that excess ROS-derived NADPH oxidase (NOX) is an important agent in hypertension. It augments blood pressure in the presence of other pro-hypertensive factors such as angiotensin II (Ang II), an important and potent regulator of cardiovascular NADPH oxidase, activates NOX via AT1 receptors. NADPH oxidase, a multi-subunit complex enzyme, is considered as a key source of ROS production in the vasculature. The activation of this enzyme is needed for assembling Rac-1, p40phox, p47phox and p67phox subunits. Since, hypertensive patients need to control blood pressure for their entire life and because drugs and other chemicals often induce adverse effects, the use of natural phenolic compounds which are less toxic and potentially beneficial may be good avenues of addition research in our understand of the underlying mechanism involved in hypertension. This review focused on several natural phenolic compounds as berberine, thymoquinone, catechin, celastrol, apocynin, resveratrol, curcumin, hesperidine and G-hesperidine, and quercetin which are NOX inhibitors. In addition, structure activity relationship of these compounds eventually as the most inhibitors was discussed. METHODS: This comprehensive review is based on pertinent papers by a selective search using relevant keywords that was collected using online search engines and databases such as ScienceDirect, Scopus and PubMed. The literature mainly focusing on natural products with therapeutic efficacies against hypertension via experimental models both in vitro and in vivo was identified. RESULTS: It has been observed that these natural compounds prevent NADPH oxidase expression and ROS production while increasing NO bioavailability. It have been reported that they improve hypertension due to formation of a stable radical with ROS-derived NADPH oxidase and preventing the assembly of NOX subunites. CONCLUSION: It is clear that natural phenolic compounds have some potential inhibitory effect on NADPH oxidase activity. In comparison to other phenolic plant compounds, the structural variability of the flavonoids should off different impacts on oxidative stress in hypertension including inhibition of nadph oxidase and direct scavenging of free radicals.


Subject(s)
Acetophenones/therapeutic use , Antioxidants/therapeutic use , Hypertension/drug therapy , NADPH Oxidases/drug effects , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Reactive Oxygen Species/metabolism , Adult , Aged , Aged, 80 and over , Animals , Female , Free Radicals/therapeutic use , Humans , Male , Middle Aged
17.
Biochem Pharmacol ; 74(6): 801-9, 2007 Sep 15.
Article in English | MEDLINE | ID: mdl-17601494

ABSTRACT

Oxidative damage to various cellular constituents (such as, proteins and lipids) mediated by reactive oxygen species (ROS) is thought to be an important mechanism underlying the pathogenesis of a variety of acute and chronic diseases. Mitochondria are the main source of ROS within most cells. Accordingly, there is increasing interest in the development of pharmacological ROS scavengers, which are specifically targeted to and concentrated within mitochondria. Numerous compounds with these general characteristics have been synthesized and evaluated in a variety of in vitro and in vivo models of redox stress. Among the more promising of these mitochondria-targeted anti-oxidants are those that employ various peptides (or peptide-like moieties) derived from the antibiotic, gramicidin S, as the targeting construct and employ the stable free radical, 4-amino-2,2,6,6-tetramethylpiperidine-N-oxyl (4-NH(2)-TEMPO), as the ROS scavenging "payload." One of these hemigramicidin-TEMPO conjugates, XJB-5-131, has been shown to ameliorate intestinal mucosal injury and prolong survival in rats subjected to lethal hemorrhage.


Subject(s)
Antioxidants/therapeutic use , Cyclic N-Oxides/therapeutic use , Mitochondria/drug effects , Reactive Oxygen Species/antagonists & inhibitors , Animals , Antioxidants/pharmacology , Cyclic N-Oxides/pharmacology , Free Radicals/pharmacology , Free Radicals/therapeutic use , Gramicidin , Humans , Mitochondria/metabolism
19.
Phytomedicine ; 23(10): 989-97, 2016 Sep 15.
Article in English | MEDLINE | ID: mdl-27444343

ABSTRACT

BACKGROUND: Oxalate and/or calcium oxalate, is known to induce free radical production, subsequently leading to renal epithelial injury. Oxidative stress and mitochondrial dysfunction have emerged as new targets for managing oxalate induced renal injury. HYPOTHESIS: Plant products and antioxidants have gained tremendous attention in the prevention of lithiatic disease. Rottlerin, a polyphenolic compound from the fruits of Mallotus phillipensis (Lam.) Müll.Arg., has shown free radical scavenging, antioxidant activity and has been reported to interfere in signaling pathways leading to inflammation and apoptosis. In this study, the potential role of rottlerin, in rats exposed to hyperoxaluric environment was explored. METHODS: Hyperoxaluria was induced by administering 0.4% ethylene glycol and 1% ammonium chloride in drinking water to male wistar rats for 9 days. Rottlerin was administered intraperitoneally at 1mg/kg/day along with the hyperoxaluric agent. Prophylactic efficacy of rottlerin to diminish hyperoxaluria induced renal dysfunctionality and crystal load was examined along with its effect on free radicals generating pathways in hyperoxaluric rats. RESULTS: 0.4% ethylene glycol and 1% ammonium chloride led to induction of hyperoxaluria, oxiadtive stress and mitochondrial damage in rats. Rottlerin treatment reduced NADPH oxidase activity, prevented mitochondrial dysfunction and maintained antioxidant environment. It also refurbished renal functioning, tissue integrity and diminished urinary crystal load in hyperoxaluric rats treated with rottlerin. CONCLUSIONS: Thus, the present investigation suggests that rottlerin evidently reduced hyperoxaluric consequences and the probable mechanism of action of this drug could be attributed to its ability to quench free radicals by itself and interrupting signaling pathways involved in pathogenesis of stone formation.


Subject(s)
Acetophenones/pharmacology , Acute Kidney Injury/chemically induced , Acute Kidney Injury/drug therapy , Antioxidants/pharmacology , Calcium Oxalate/metabolism , Free Radicals/metabolism , Oxidative Stress/drug effects , Acetophenones/therapeutic use , Animals , Antioxidants/therapeutic use , Calcium Oxalate/therapeutic use , Free Radicals/therapeutic use , Fruit/chemistry , India , Male , Mallotus Plant/chemistry , Oxidation-Reduction , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Rats , Rats, Wistar
20.
Clin Hemorheol Microcirc ; 33(1): 19-28, 2005.
Article in English | MEDLINE | ID: mdl-16037629

ABSTRACT

Ischemic preconditioning is a condition of reduced sensitivity to ischemic damage. This protective state can be induced by exposure to periods of brief, sublethal, ischemia prior to a protracted ischemic event, but, more interestingly, also by administration of specific drugs. Recent studies have emphasized the central role of free radicals (including superoxide anion and nitric oxide) in this process. In line with these observations, studies have demonstrated that also drugs such as organic nitrates, which are able to release nitric oxide (but also the highly oxidant superoxide anion) can induce preconditioning. Starting from our observations made in human experimental models regarding the effects of chronic therapy with organic nitrates, we criticize the hypothesis whereby nitrates might be used to induce a state similar to preconditioning upon chronic exposure. As well, we propose a theory for the evolutionary meaning of ischemic preconditioning based on the hypothesis that, while protective over short periods of time, continuous exposure to oxidant free radicals might be associated with a loss of this protective effect and, in certain cases, with an increased oxidative damage.


Subject(s)
Free Radicals/therapeutic use , Ischemic Preconditioning/methods , Biological Evolution , Humans , Myocardial Ischemia/etiology , Myocardial Ischemia/prevention & control , Nitrates/adverse effects , Nitrates/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL